Promoted Content Promoted Content

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Bitopertin

            Therapeutic Area: Rare Diseases and Disorders Product Name: RO4917838

            Highest Development Status: Preclinical Product Type: Small molecule

            Partner/Sponsor/Collaborator: Disc medicine

            Deal Size: $200.0 million Upfront Cash: Undisclosed

            Deal Type: Collaboration May 27, 2021

            Details:

            Under the terms of the agreement, Disc Medicine will obtain exclusive, global rights to and be responsible for all development, manufacturing, and commercialization of bitopertin and related back up compounds.